Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage

Stroke

Volumn 27, Issue 10, 1996, Pages 1739-1743

  Akopov, S E ^a,b   Simonian, N A ^a   Grigorian, G S ^a  

^a Republican Children's Hospital   (Armenia)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

leukocytes; neuronal damage; stroke outcome; tomography, emission computed

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; NERVE CELL LESION; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE;

EID: 0029780302     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.10.1739     Document Type: Article

References (27)

1. Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke. 1992;23:1367-1379.
2. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol. 1994; 55:662-675.
3. Mullane K. Neutrophil and endothelial changes in reperfusion injury. Trends Cardiovasc Med. 1991;1:282-289.
4. Hallenbeck JM, Dutka AJ. Background review and current concepts of reperfusion injury. Arch Neurol. 1990;47:1245-1254.
5. Pozzilli C, Lenzi GL, Argentino C, Carolei A, Rasura M, Signore A, Bozzano L, Pozzilli P. Imaging of leukocytic accumulation in human cerebral infarcts. Stroke. 1985;16:251-255.
6. Wang P-Y, Kao C-H, Mui M-Y. Wang S-J. Leukocyte accumulation in acute hemispheric ischemic stroke. Stroke. 1993;24:236-240.
7. Wong MCW, Haley EC. Calcium antagonists: stroke therapy coming of age. Stroke. 1990;21:494-501.
8. Grotta JC. Clinical aspects of the use of calcium antagonists in cerebrovascular disease. Clin Neuropharmacol. 1991;14:373-390.
9. Akopov SE. Calcium antagonists in cerebral ischemia: experimental basis and clinical experience. Drugs Today. 1994;30:171-210.
10. Brierly JB. Graham DI. Hypoxia and vascular disorders of the central nervous system. In: Adams J, Corsellis JAN, Duchen LW, eds. Greenfield's Neuropathology. Baltimore, Md: Edward Arnold Ltd; 1984:126-207.
11. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989; 320:365-376.
12. Mathew NT, Meyer JS, Rivera VH, Charney JZ, Hartmann A. A double blind evaluation of glycerol treatment in acute cerebral infarction. Lancet. 1972;2:1327-1329.
13. Gelmers HJ, Hennerici M. Effect of nimodipine on acute ischemic stroke. Stroke. 1990;21(suppl IV):IV-81-IV-84.
14. Martinez-Vila E, Guillen F, Villanueva J, Matias-Guiu J, Bigorra J, Gil P, Carbonell A, Martinez-Lage J. Placebo-controlled trial of nimodipine in the treatment of acute ischemic cerebral infarction. Stroke. 1990;21:1023-1028.
15. Kao CH, Wang PY, Wang YL, Chang L, Wang SJ, Yeh SH. A new prognostic index - leukocyte accumulation - in human cerebral infarcts by 99Tcm-HMPAO-labeled white blood cell brain SPECT. Nucl Med Commun. 1991;12:1007-1012.
16. English D, Andersen BR. Single step separation of red blood cells, granulocytes and mononuclear leukocytes on discontinuous density gradients of ficoll-hypaque. J Immunol Meth. 1974;5:249-252.
17. Uno K, Imazeki K, Yoshikawa K, Arimizu N. Clinical use of technetium-99 m HMPAO labeled leukocyte for inflammatory imaging. J Nucl Med. 1987;28:648.
18. Laloux P, Richelle F, Jamart J, De Coster P, Laterre C. Comparative correlations of HMPAO SPECT indices, neurological score, and stroke subtypes with clinical outcome in acute carotid infarcts. Stroke. 1995;26:816-821.
19. Brott T, Marier JR, Olinger CP, Adams HP, Tomsick T, Barsan WG, Biller J, Eberle R, Hertzberg V, Walker M. Measurement of acute cerebral infarction: lesion size by computed tomography. Stroke. 1989;20:871-975.
20. Hair JF, Anderson RE, Tatham RL, Black WC. Multivariate Data Analysis. New York, NY: Macmillan Publishing Co; 1992.
21. Lucchesi BR. Complement activation, neutrophils. and oxygen radicals in reperfusion injury. Stroke. 1993;24(suppl I):I-41-I-49.
22. Lefer AM, Ma XL. Cytokines and growth factors in endothelial dysfunction. Crit Care Med. 1993;21(suppl 2):S9-S14.
23. Tedgui A, Bernard C. Cytokines, immuno-inflammatory response and atherosclerosis. Eur Cytokine Netw. 1994;5:263-270.
24. Akopov S, Sercombe R, Seylaz J. Cerebrovascular reactivity: role of endothelium/platelet/leukocyte interactions. Cerebrovasc Brain Metab Reviews. 1996;8:11-94.
25. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068-2101.
26. Bazzoni G, DaJana E, Del Maschio A. Platelet-neutrophil interactions: possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica. 1991;76:491-499.
27. Strangaard S, Paulson OB. Pathophysiology of stroke. J Cardiovasc Pharmacol. 1990;15(suppl 1):S38-S42.